Saturday, October 7, 2017

Pharma Reviews: Profits from Copaxone generics to help strengthen balance sheet, expansion: Natco CEO

Copaxone is by far the biggest ever generic approval in 2017 for Indian generic pharma industry in US. The drug is the most prescribed multiple ...
Read more: Profits from Copaxone generics to help strengthen balance sheet, expansion: Natco CEO